ABT - Adjustment

The following adjustment was made today on Abbott Laboratories (ABT). All prices include IB commissions.

This is the second position on ABT. The first position is a CC.

Criteria	Value
Dividend Champions Status	Champion
Years of Consecutive Dividend Increases	38
Years of Positive Free Cash Flow (last 10 years)	10
Fair Value Estimate	$68.00
Target Buy Price	$55.00
Target Margin of Safety	20.00%
Actual Buy Price	$52.50
Actual Margin of Safety	22.79%

Date	Stock	Description	Transaction	Status	Stock Investment	Income Generated
8/19/2011	ABT	CSP Margin Returned	CSP 100 ABT @ -52.50		$5,250.00
8/19/2011	ABT	Stock Assigned	EX 1 Aug11 52.50 Put @ -52.50		($5,250.00)
8/24/2011	ABT	Continued Trade	STO 1 Oct11 52.50 Call @ 1.00			$99.98

Current Position Summary

Cost Basis	($5,250.00)
Income Generated	$292.38
Percent Income Generated	5.57%
Annualized Income Generated	13.11%
Net Profit If Assigned	$292.38
Percent Return If Assigned	5.57%
Annualized Return If Assigned	13.11%
Days Held to Expiration	155 days

Trade History

Date	Stock	Description	Transaction	Status	Stock Investment	Income Generated
5/19/2011	ABT	CSP Margin Used	CSP 100 ABT @ 52.50		($5,250.00)
5/19/2011	ABT	Initial Put Option	STO 1 Jun11 52.50 Put @ 0.55	Closed		$55.34
6/17/2011	ABT	Buy Back and Roll Out	BTC 1 Jun11 52.50 Put @ -0.82			($81.97)
6/17/2011	ABT	Continued Trade	STO 1 Aug11 52.50 Put @ 2.19	Exercised		$219.03
8/19/2011	ABT	CSP Margin Returned	CSP 100 ABT @ -52.50		$5,250.00
8/19/2011	ABT	Stock Assigned	EX 1 Aug11 52.50 Put @ -52.50		($5,250.00)
8/24/2011	ABT	Continued Trade	STO 1 Oct11 52.50 Call @ 1.00			$99.98
10/21/2011	ABT		Totals		($5,250.00)	$292.38
DTE	155		Percent Income/Annualized		5.57%	13.11%